Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Is BRCA1 the Link Between Infertility and Breast/Ovarian Cancer?
Link ID 23151
Title Is BRCA1 the Link Between Infertility and Breast/Ovarian Cancer?
Url http://www.medscape.com/viewarticle/717719?src=rss
Description Dr. Maurie Markman reports on a study indicating BRCA1 mutations -- well known as risk factors for breast and ovarian cancer -- may also be related to primary occult ovarian insufficiency. Medscape Hematology-Oncology
Category Articles > Hematology-Oncology
Keywords
Date Mar 11, 2010
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. Genetic Variant Increases Risk for Glioblastoma Multiforme in Young Patients
  The variation of a single amino acid in tumor protein 53 may have greater effect on GBM risk in patients younger than 45 years. Medscape Medical News
Category:   Articles > Hematology-Oncology


2. ASCO 2009: Avoid SSRIs in Breast Cancer Patients on Tamoxifen
  Breast cancer survivors taking tamoxifen to reduce the risk for recurrence should avoid concomitant use of fluoxetine, paroxetine, and sertraline, say experts. Medscape Medical News
Category:   Articles > Hematology-Oncology


3. Bevacizumab for Breast Cancer Hotly Debated
  Over the past week, as an FDA decision is awaited, a flurry of media reports has led to a debate about the use of bevacizumab in breast cancer. Medscape Medical News
Category:   Articles > Hematology-Oncology


4. Important Changes to NCCN Guideline on NHL
  Changes in the treatment and assessment of follicular lymphoma and an entirely new section on lymphoproliferative disorder highlight the updated guideline. Medscape Medical News
Category:   Articles > Hematology-Oncology


5. Time to Celebrate; New Metastatic Melanoma Agent Wows ASCOTime to Celebrate; New Metastatic Melanoma
  The BRAF inhibitor, with phase 3 data now available, continues to impress with its effectiveness. br / iMedscape Medical News/i
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS